{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T11:18:08Z","timestamp":1770549488357,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41401-022-00873-y","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T09:02:49Z","timestamp":1646038969000},"page":"2666-2677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Scutellarin suppresses triple-negative breast cancer metastasis by inhibiting TNF\u03b1-induced vascular endothelial barrier breakdown"],"prefix":"10.1038","volume":"43","author":[{"given":"Xi-yu","family":"Mei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-ya","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-li","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"873_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438\u201351.","journal-title":"CA Cancer J Clin"},{"key":"873_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389:1134\u201350.","journal-title":"Lancet."},{"key":"873_CR3","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271\u20137.","journal-title":"J Clin Oncol"},{"key":"873_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288\u2013300.","journal-title":"JAMA."},{"key":"873_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61\u20138.","journal-title":"Cancer Lett"},{"key":"873_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell."},{"key":"873_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nrclinonc.2012.120","volume":"9","author":"A Albini","year":"2012","unstructured":"Albini A, Tosetti F, Li VW, Noonan DM, Li WW. Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol. 2012;9:498\u2013509.","journal-title":"Nat Rev Clin Oncol"},{"key":"873_CR8","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1158\/1078-0432.CCR-17-0874","volume":"23","author":"S Ueda","year":"2017","unstructured":"Ueda S, Saeki T, Osaki A, Yamane T, Kuji I. Bevacizumab induces acute hypoxia and cancer progression in patients with refractory breast cancer: multimodal functional imaging and multiplex cytokine analysis. Clin Cancer Res. 2017;23:5769\u201378.","journal-title":"Clin Cancer Res"},{"key":"873_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1152\/physrev.00035.2003","volume":"84","author":"G Bazzoni","year":"2004","unstructured":"Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84:869\u2013901.","journal-title":"Physiol Rev"},{"key":"873_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tips.2019.07.001","volume":"40","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang Y, Huang Y, Kim B, Shan H, Wu D, et al. Tumor vasculatures: a new target for cancer immunotherapy. Trends Pharmacol Sci. 2019;40:613\u201323.","journal-title":"Trends Pharmacol Sci."},{"key":"873_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larriv\u00e9e B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20:409\u201326.","journal-title":"Angiogenesis."},{"key":"873_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ccell.2016.10.018","volume":"30","author":"JS Park","year":"2016","unstructured":"Park JS, Kim IK, Han S, Park I, Kim C, Bae J, et al. Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment. Cancer Cell. 2016;30:953\u201367.","journal-title":"Cancer Cell"},{"key":"873_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10911-010-9186-9","volume":"15","author":"AC Andres","year":"2010","unstructured":"Andres AC, Djonov V. The mammary gland vasculature revisited. J Mammary Gland Biol Neoplasia. 2010;15:319\u201328.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"873_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","volume":"43","author":"D Cruceriu","year":"2020","unstructured":"Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-alpha) in breast cancer: molecular insights and therapeutic approaches. Cell Oncol. 2020;43:1\u201318.","journal-title":"Cell Oncol"},{"key":"873_CR15","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","volume":"14","author":"BE Lippitz","year":"2013","unstructured":"Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14:e218\u201328.","journal-title":"Lancet Oncol"},{"key":"873_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/0008-5472.CAN-07-5704","volume":"68","author":"JH Egberts","year":"2008","unstructured":"Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res. 2008;68:1443\u201350.","journal-title":"Cancer Res"},{"key":"873_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumor necrosis factor and cancer. Nat Rev Cancer. 2009;9:361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"873_CR18","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1158\/1078-0432.CCR-04-0730","volume":"10","author":"S Madhusudan","year":"2004","unstructured":"Madhusudan S, Foster M, Muthuramalingam SR, Braybrooke JP, Wilner S, Kaur K, et al. A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res. 2004;10:6528\u201334.","journal-title":"Clin Cancer Res"},{"key":"873_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2016","unstructured":"Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"873_CR20","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.4049\/jimmunol.1203195","volume":"192","author":"X Hu","year":"2014","unstructured":"Hu X, Li B, Li X, Zhao X, Wan L, Lin G, et al. Transmembrane TNF-\u03b1 promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. J Immunol. 2014;192:1320\u201331.","journal-title":"J Immunol"},{"key":"873_CR21","unstructured":"Commission CP. Pharmacopoeia of the People\u2019s Republic of China (2020 version). Beijing: The Medicine Science and Technology Press of China; 2020. p. 872\u20131110."},{"key":"873_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fphar.2017.00289","volume":"8","author":"J Gao","year":"2017","unstructured":"Gao J, Chen G, He H, Liu C, Xiong X, Li J, et al. Therapeutic effects of breviscapine in cardiovascular diseases: a review. Front Pharmacol. 2017;8:289.","journal-title":"Front Pharmacol"},{"key":"873_CR23","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1111\/jcmm.14169","volume":"23","author":"K Liu","year":"2019","unstructured":"Liu K, Tian T, Zheng Y, Zhou L, Dai C, Wang M, et al. Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2\/STAT3 pathway. J Cell Mol Med. 2019;23:3040\u20134.","journal-title":"J Cell Mol Med"},{"key":"873_CR24","doi-asserted-by":"publisher","first-page":"23169","DOI":"10.1002\/jcp.28883","volume":"234","author":"WL Lv","year":"2019","unstructured":"Lv WL, Liu Q, An JH, Song XY. Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells. J Cell Physiol. 2019;234:23169\u201375.","journal-title":"J Cell Physiol"},{"key":"873_CR25","first-page":"5094","volume":"9","author":"PT Zhu","year":"2017","unstructured":"Zhu PT, Mao M, Liu ZG, Tao L, Yan BC. Scutellarin suppresses human colorectal cancer metastasis and angiogenesis by targeting ephrinb2. Am J Transl Res. 2017;9:5094\u2013104.","journal-title":"Am J Transl Res"},{"key":"873_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00196-1","volume":"8","author":"D Boral","year":"2017","unstructured":"Boral D, Vishnoi M, Liu HN, Yin W, Sprouse ML, Scamardo A, et al. Molecular characterization of breast cancer CTCs associated with brain metastasis. Nat Commun. 2017;8:196.","journal-title":"Nat Commun"},{"key":"873_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.expneurol.2006.07.023","volume":"203","author":"C Yu","year":"2007","unstructured":"Yu C, Kastin AJ, Ding Y, Pan W. Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Exp Neurol. 2007;203:116\u201322.","journal-title":"Exp Neurol"},{"key":"873_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bcp.2018.11.011","volume":"159","author":"X Mei","year":"2019","unstructured":"Mei X, Zhang T, Ouyang H, Lu B, Wang Z, Ji L. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy. Biochem Pharmacol. 2019;159:82\u201395.","journal-title":"Biochem Pharmacol"},{"key":"873_CR29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","volume":"97","author":"A Armulik","year":"2005","unstructured":"Armulik A, Abramsson A, Betsholtz C. Endothelial\/pericyte interactions. Circ Res. 2005;97:512\u201323.","journal-title":"Circ Res"},{"key":"873_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/CIRCRESAHA.117.312392","volume":"122","author":"MF Morini","year":"2018","unstructured":"Morini MF, Giampietro C, Corada M, Pisati F, Lavarone E, Cunha SI, et al. VE-cadherin-mediated epigenetic regulation of endothelial gene expression. Circ Res. 2018;122:231\u201345.","journal-title":"Circ Res"},{"key":"873_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","volume":"14","author":"R Cao","year":"2004","unstructured":"Cao R, Zhang Y. The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev. 2004;14:155\u201364.","journal-title":"Curr Opin Genet Dev"},{"key":"873_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/OTT.S187426","volume":"12","author":"SL Tang","year":"2019","unstructured":"Tang SL, Gao YL, Hu WZ. Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells. Onco Targets Ther. 2019;12:587\u201398.","journal-title":"Onco Targets Ther"},{"key":"873_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbrc.2016.12.114","volume":"483","author":"Y Ke","year":"2017","unstructured":"Ke Y, Bao T, Wu X, Tang H, Wang Y, Ge J, et al. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3\/Girdin\/Akt activity. Biochem Biophys Res Commun. 2017;483:509\u201315.","journal-title":"Biochem Biophys Res Commun"},{"key":"873_CR34","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3892\/ijo.2013.1873","volume":"42","author":"H Li","year":"2013","unstructured":"Li H, Huang D, Gao Z, Chen Y, Zhang L, Zheng J. Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and alphavbeta6 integrin. Int J Oncol. 2013;42:1674\u201381.","journal-title":"Int J Oncol"},{"key":"873_CR35","doi-asserted-by":"publisher","first-page":"172463","DOI":"10.1016\/j.ejphar.2019.172463","volume":"858","author":"CY Li","year":"2019","unstructured":"Li CY, Wang Q, Wang X, Li G, Shen S, Wei X. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K\/Akt\/mTOR signaling pathway. Eur J Pharmacol. 2019;858:172463.","journal-title":"Eur J Pharmacol"},{"key":"873_CR36","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.12659\/MSM.904492","volume":"23","author":"L Hou","year":"2017","unstructured":"Hou L, Chen L, Fang L. Scutellarin inhibits proliferation, invasion, and tumorigenicity in human breast cancer cells by regulating HIPPO-YAP signaling pathway. Med Sci Monit. 2017;23:5130\u20138.","journal-title":"Med Sci Monit"},{"key":"873_CR37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, Cao X. Characteristics and significance of the pre-metastatic niche. Cancer Cell. 2016;30:668\u201381.","journal-title":"Cancer Cell"},{"key":"873_CR38","doi-asserted-by":"publisher","first-page":"9815","DOI":"10.1073\/pnas.96.17.9815","volume":"96","author":"M Corada","year":"1999","unstructured":"Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA. 1999;96:9815\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"873_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.addr.2005.01.009","volume":"57","author":"GJ Feldman","year":"2005","unstructured":"Feldman GJ, Mullin JM, Ryan MP. Occludin: structure, function and regulation. Adv Drug Deliv Rev. 2005;57:883\u2013917.","journal-title":"Adv Drug Deliv Rev"},{"key":"873_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/CIRCRESAHA.116.306534","volume":"120","author":"YA Komarova","year":"2017","unstructured":"Komarova YA, Kruse K, Mehta D, Malik AB. Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability. Circ Res. 2017;120:179\u2013206.","journal-title":"Circ Res"},{"key":"873_CR41","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cub.2013.04.049","volume":"23","author":"DE Conway","year":"2013","unstructured":"Conway DE, Breckenridge MT, Hinde E, Gratton E, Chen CS, Schwartz MA. Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Curr Biol. 2013;23:1024\u201330.","journal-title":"Curr Biol"},{"key":"873_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","volume":"23","author":"P Lertkiatmongkol","year":"2016","unstructured":"Lertkiatmongkol P, Liao D, Mei H, Hu Y, Newman PJ. Endothelial functions of platelet\/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol. 2016;23:253\u20139.","journal-title":"Curr Opin Hematol"},{"key":"873_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ccr.2010.10.035","volume":"19","author":"CJ Chang","year":"2011","unstructured":"Chang CJ, Yang JY, Xia W, Chen CT, Xie X, Chao CH, et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell. 2011;19:86\u2013100.","journal-title":"Cancer Cell"},{"key":"873_CR44","doi-asserted-by":"publisher","first-page":"11606","DOI":"10.1073\/pnas.1933744100","volume":"100","author":"CG Kleer","year":"2003","unstructured":"Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA. 2003;100:11606\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"873_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","volume":"22","author":"KH Kim","year":"2016","unstructured":"Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22:128\u201334.","journal-title":"Nat Med"},{"key":"873_CR46","doi-asserted-by":"publisher","first-page":"19010","DOI":"10.1002\/jcp.28540","volume":"234","author":"S Ning","year":"2019","unstructured":"Ning S, Ma X. Dephosphorylation-induced EZH2 activation mediated RECK downregulation by ERK1\/2 signaling. J Cell Physiol. 2019;234:19010\u20138.","journal-title":"J Cell Physiol"},{"key":"873_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.molcel.2017.12.024","volume":"69","author":"L Wan","year":"2018","unstructured":"Wan L, Xu K, Wei Y, Zhang J, Han T, Fry C, et al. Phosphorylation of EZH2 by AMPK suppresses PRC2 methyltransferase activity and oncogenic function. Mol Cell. 2018;69:279\u201391.","journal-title":"Mol Cell"},{"key":"873_CR48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.01070.x","volume":"162","author":"Z Pan","year":"2011","unstructured":"Pan Z, Zhao W, Zhang X, Wang B, Wang J, Sun X, et al. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1\/2. Br J Pharmacol. 2011;162:688\u2013700.","journal-title":"Br J Pharmacol"},{"key":"873_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12929-017-0398-9","volume":"24","author":"I Mart\u00ednez-Reza","year":"2017","unstructured":"Mart\u00ednez-Reza I, D\u00edaz L, Garc\u00eda-Becerra R. Preclinical and clinical aspects of TNF-\u03b1 and its receptors TNFR1 and TNFR2 in breast cancer. J Biomed Sci. 2017;24:90.","journal-title":"J Biomed Sci"},{"key":"873_CR50","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.molmed.2017.09.007","volume":"23","author":"\u00c9S Vanamee","year":"2017","unstructured":"Vanamee \u00c9S, Faustman DL. TNFR2: a novel target for cancer immunotherapy. Trends Mol Med. 2017;23:1037\u201346.","journal-title":"Trends Mol Med"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00873-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T02:04:06Z","timestamp":1664589846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00873-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["873"],"URL":"https:\/\/doi.org\/10.1038\/s41401-022-00873-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}